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Abstract
Uncertainty around the role ‘super-spreaders’ play in the transmission and escalation of
infectious disease is compounded by its broad and vague definition. It is a term that has
been much used in relation to COVID-19, particularly in social media. On its widest
definition, it refers to a propensity to infect a larger than average number of people. Given
the biological, behavioural and environmental variables relevant to infectivity, this might be
pertinent to almost any infected individual who is not physically isolated from others. Nor
is the term confined to individuals with a propensity to spread infectious disease: it can
potentially be used to describe events, policies or settings. This article explores the use of
the term and considers circumstances in which the wide definition can be problematic. One
problem is that it can lead to undeserved apportionment of moral blame to alleged super-
spreaders. Another is that it can detract from scientific investigation of the heterogeneity of
COVID-19 transmission. The author calls for a clearer epidemiological definition.
Keywords Confidentiality . Coronavirus . COVID-19 . Privacy . Super-spreader . Super-
spreading
Introduction: COVID-19 Super-spreaders
At the time of writing, exit strategies from COVID-19 lockdown are unclear, but de-
escalation of physical distancing measures is likely to be gradual. One aspect of
shielding the vulnerable is to identify those at risk of developing serious and potentially
life-threatening symptoms and distance them from sources of infection. More work is
needed to identify such groups, which include people over the age of 65 and those with
underlying health conditions. Another is to identify and isolate the infected. This is
complicated by uncertainty as to whether efforts to produce a vaccine will succeed and
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how long it will take. It is possible that post-infection immunity may be short-lived
(European Centre for Disease Prevention and Control (ECDC) 2020, 9), and even if
infection confers immunity, the ECDC estimates that 67% of the population would
need to have had the virus in order to prevent ongoing transmission and that ‘Some
form of physical distancing interventions will therefore need to be in place for at least
several months from now’ (2020, 18). A second wave (and potentially further waves)
of COVID-19 is possible (Xu and Li 2020).
The ECDC (2020, 7) estimates that the reproductive number (R0) of COVID-19 in
EU/EEA countries is 3.28. That is, a person contracting the novel virus will pass it on to
an average of around 3 people. The R0 is a measure of potential transmissibility that is
difficult to establish, particularly if the accuracy of the data is questionable as where, for
example, there is under- or mis-reporting. Underlying the R0 is a considerable variation
which, early in the outbreak, Mackenzie (2020) postulated may be down to the role of
super-spreaders: around 10% of cases could be responsible for up to 80% of transmis-
sion. If so, she argued, control of super-spreading would be essential in tackling the
outbreak.
The situation is complicated by the fact that so-called super-spreaders of COVID-19
cannot always self-identify and take steps to mitigate the risk to others. The virus has
been detected 1–3 days before onset of symptoms, and the ECDC sees this as a
potential major source of transmission. Some individuals are asymptomatic throughout,
though the risk of transmission is probably somewhat lower in such cases. There have
also been reports of COVID-19 positive tests during convalescence, following a
negative test (Chen et al. 2020). COVID-19 may itself have super-spreading tendencies
flowing from the occurrence of atypical symptoms (Wang et al. 2020), which may have
led to a failure to identify many mild cases—a phenomenon that has been exacerbated
by limited and variable availability of testing, tracing and screening.
In light of the importance of identifying and controlling infection, this article begins
by considering the definition of ‘super-spreader’ and argues that the term is vague and
unhelpful. It goes on to demonstrate ways in which it has been applied to impute moral
condemnation on individuals accused of spreading COVID-19 and calls for the
development of a clearer and widely held scientific definition of super-spread that
accommodates the relevance of individual factors in disease transmission without
attributing moral blame.
A Term of Art
The term ‘super-spreader’ has recently entered our consciousness, alongside words such as
‘comorbidity’, ‘furlough’ and ‘lockdown’. A super-spreader, usually identified in retrospect,
has a greater than average propensity to infect a larger number of people. Super-spreading is
not a new phenomenon: symptomless ‘Typhoid Mary’ was exiled for 26 years for appar-
ently infecting many others in the 1800s (Marineli et al. 2013), and super-spreading was
thought to be a driver of MERS, SARS (2002–2003) and, to a lesser extent, Ebola (Wong
et al. 2015). Stein (2011) observes that observational and modelling studies support a 20/80
rule whereby 20% of individuals are likely to contribute around 80% of the transmission
potential in a given infectious disease. Many variables make up this tendency, and this has
potential to limit the meaningfulness of the term.
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The label ‘super-spreader’ is a term of art that has been utilised to describe settings,
events and individuals. Super-spreading settings include cruise ships and aeroplanes as
well as hospitals, care homes and potentially schools, particularly where they utilise
ventilation systems. As for events, any large gathering or movement of groups or
individuals can constitute super-spreading. So too can policy decisions or indeed any
occurrence which in hindsight exacerbated infection rates, such as the lack of control
measures when SARS first emerged and single cases were treated as atypical pneumo-
nia and transmitted to others (WHO 2003). As highlighted above, COVID-19 itself has
super-spreading tendencies given its potential for atypical symptoms and pre-
symptomatic and asymptomatic transmission.
The term is particularly problematic when applied to individual ‘super-spreaders’, as
it can mean different things to different groups. Media interest in super-spreaders
focuses on the early stages of the epidemic when efforts are being made to contain,
trace and delay. Used in this way, a ‘super-spreader’ will generally have interacted with
a larger than average number of people, making tracing difficult or impossible. At the
other end of the spectrum, scientific interest can focus on the heterogeneity of popu-
lations in the transmission of infectious disease. Used in this sense, ‘super-spreading’ is
connected to the scientific nature of the virus and the way it manifests in some humans.
There is speculation that some people with COVID-19 are especially infectious
(Boseley and Belam 2020).
Super-spreading is therefore a product of biological, behavioural and environmental
factors. It can be used to describe decisions, policies, events, settings and individuals—
in fact, anything that contributes to increased rates of infection can be seen (by some
groups) as super-spreading. The wide and varied use of the term ‘super-spreader’ is
problematic for two reasons considered in subsequent sections: it can lead to appor-
tionment of moral blame to alleged super-spreaders and it could detract from scientific
investigation into heterogeneity of COVID-19 if misunderstanding leads to diminished
public support and trust.
Blaming Super-spreaders
Alleged super-spreaders of COVID-19 have attracted considerable media interest.
Patient 31, a member of the Shincheonji church, was thought to have turned the tide
in South Korea (Kasulis 2020). As the number of deaths increased, anger was directed
at the church, and the founder’s apology was broadcast around the world. In India, the
state of Punjab quarantined 40,000 people following around 30 deaths linked to a 70-
year-old preacher who died of the disease (BBC News 2020). In the UK, a Brighton
businessperson was labelled a ‘culprit’ early in the course of COVID-19 (see Ball 2020
for criticism). Each was labelled by parts of the media a ‘super-spreader’ whether or not
the host was aware of the risks they posed to others or the repercussions their infection
could have. These factors were not always reflected in media reports.
There is a public interest in the location and number of cases, and in the early days of
the crisis, when cases were few, this may have enabled some to piece together the
identity of infected individuals. The Brighton case in England resulted in ‘super-
spreader’ headline claims from newspapers including the Daily Mail, Guardian, Sun
and Telegraph. The individual came forward to reveal the steps he had taken on
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learning that he had come into contact with a COVID-19-positive person, allegedly due
to fears of scapegoating (Duggan et al. 2020). Turn to Twitter and #superspreaders has
been employed as a term to signal moral blame, aimed at individuals and groups
including political leaders, runners, cyclists and the police.
Opprobrium may rightly follow if a symptomatic individual knowingly puts others
at risk in avoidable circumstances, such as the reported cases of people deliberately
coughing in the faces of others. However, to attach moral blame to those labelled after
the event as super-spreaders is highly problematic, most obviously because carriers of
COVID-19 can be asymptomatic, but also because the label can be stigmatising and
potentially deter the symptomatic from coming forward if they have recently been in
contact with large or vulnerable numbers. Spreading can be exacerbated by poor
hygiene or certain social practices such as hand shaking, but infection of others is not
evidence alone that guidelines on behaviour have been ignored. Sadly, as the pandemic
and resulting fear have escalated, so have examples of the public viewing anyone
‘other’ as a potential super-spreader (Coates 2020).
Delivering Ethical Research on Heterogeneity of COVID-19
Transmission
Another problem with the term ‘super-spreader’ is that its wide use has potential to
detract from its importance in research on heterogeneity of transmission of COVID-19.
If ‘super-spreader’ is understood in lay terms to attract varying degrees of moral blame,
then epidemiological investigation of its incidence may be less likely to gain public
support and understanding.
There is a paucity of scientific evidence of the role or even the existence of especially
infectious people with COVID-19. On a narrow scientific definition, a super-spreader would
have particular biological characteristics that would increase the tendency to infect others.
For example, a mouse model study by Gopinath et al. (2014) demonstrated the super-
spreading tendencies of a minority of mice infected with Salmonella. If any potential
biological super-spreading tendencies of COVID-19 were better understood, then it could
aid management and control through, for example, isolation or targeted vaccination if and
when it becomes available. Research might usefully focus on the tendency of some
individuals to shed high levels of the pathogen, including investigation of co-morbidity,
genetics, viral load and infectivity at different stages of presentation. In COVID-19, the
relationship between viral load, severity and infectivity is complex and poorly understood.
Increased viral load does not necessarily result in more severe symptoms (Geddes 2020),
and infection dose is currently uncertain. Clearly, the propensity for biological factors to lead
to infection of others is highly dependent on behavioural and environmental factors.
Thus, a broader definition of super-spreading might encompass research on biological
and external factors, combining focus on the virus, the host and the environment. Pre-
COVID-19, Lloyd-Smith et al. (2005) argued that control measures for infectious disease
that focus on individual-specific measures can outperform population-basedmeasures. They
proposed a rigorous protocol for defining super-spreading events that would supplement the
R0 with information about factors such as distribution and range. Research bringing greater
clarity as to the factors that drive variations in infectivity would contribute to targeted control
policies that could reduce reliance on widespread lockdown.
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However, such research is likely to be reliant upon the public giving up their
confidential data or at least cooperating if such data are mandated. Technology
offers a potential to track, predict, trace contacts and respond in a more precise
manner. There are, for example, several apps in development/use. Some allow
users to report symptoms so that more can be learned about how the virus
behaves, some give people advice on the basis of reported symptoms and some
operate in conjunction with testing to alert individuals with whom an infected
person has come into contact, to isolate. These apps offer potential to learn
more about heterogeneity and also to implement more targeted control measures
in response. In many countries, efficacy will be reliant on the willingness of
individuals to sign up to the apps. Those individuals will need assurance that
their privacy will be respected and that negative implications will not flow from
their identification as a perceived ‘super-spreader’.
Some governments are making more extensive use of confidential informa-
tion that does not rely on patient consent. In the UK, National Health Service
(NHS) England and Improvement and NHSX (the unit driving digital transfor-
mation of care) have announced the development of a digital platform that will
bring together health data, AI and cloud computing (Gould et al. 2020). They
are investing in the help of private companies such as Microsoft, Google and
Amazon Web services to bring this about. They have provided assurances that
the data ‘will remain under NHS England and NHS Improvement’s control’ and
that the data will be destroyed or returned when the emergency is over (Gould
et al. 2020). The dashboard will give metrics about occupancy levels in
hospitals and capacity and will enable decision-makers to ‘Understand how
the virus is spreading at a local level and identify risks to particularly vulner-
able populations’.
On 20 March 2020, the Department of Health and Social Care (DHSC), on behalf
of the Secretary of State for Health and Social Care, issued a notice under Regu-
lation 3(4) of the Health Service (Control of Patient Information) Regulations 2002
(COPI). Regulation 3(4) allows the Secretary of State, having had independent
advice from the Confidentiality Advisory Group, to give notice to health organisa-
tions, general practices and local authorities that confidential information will be
required (DHSC 2020) for a certain purpose. The purpose in this case is COVID-19
and includes understanding risks and trends including (amongst other things):
locating, contacting, screening, flagging and monitoring such patients and
collecting information about and providing services in relation to testing, diag-
nosis, self-isolation, fitness to work, treatment, medical and social interventions
and recovery from Covid-19. (DHSC 2020, 2)
This widely framed notice mandates the processing and sharing of confidential
information, in circumstances where patients have not given informed consent.
Together with the proposals to share information with private companies for the
production of the Dashboard, it is a high-risk strategy that will have profound
implications if public trust is undermined. Whilst efforts will be made to
protect the identity of the patients, anonymity is not a binary concept and, as
argued above in relation to the Brighton case, media interest in ‘super-
Asian Bioethics Review
spreaders’ could lead to ‘jigsaw identifiability’ and to moral blame, which in
turn could impact on trust.
A Change in Terminology?
The term ‘super-spreader’ makes an exciting headline, but its employment in
social media sometimes lacks a scientific basis. Rather it often points to
unintended action or is suggestive of negligent actions of an individual and
apportions moral blame. And yet, it is essential that we promote a culture of
ethical research on the biological, behavioural and environmental influences on
transmission.
The argument set out in this article is that the definition is too broad to be
helpful and that its (mis)use in some social media has resulted in negative
connotations. Consideration of the tendencies of individuals to exacerbate
infection rates is a worthy focus of research. As more targeted public health
responses are developed to replace widespread physical distancing policies, it is
increasingly important that heterogeneity of COVID-19 transmission is explored
and factored into responses. To the extent that super-spreading is an aspect of
research on heterogeneity, there is a risk that the negative connotations the term
has attracted will result in public reticence to give up the private information
upon which that research might depend. Greater accuracy of definition would
help ensure that debate around the term is not at cross-purposes, help reduce or
prevent moral blame of those who unwittingly infect others and could enhance
public trust around the use of confidential data.
The aim of this article has been to draw attention to problems in the use of
the term ‘super-spreader’. Turning briefly to potential solutions, one option
would be to avoid use of the term altogether, but it is well accepted in the
scientific literature (see for example Lloyd-Smith 2005, Stein 2011, Gopinath
2014), and its abandonment could disrupt important linkage between current
and previous research. Another option would be to encourage the use of the
terms ‘super-spreading’ and ‘super-spreading events’ in epidemiology, in place
of ‘super-spreader’. This might reduce stigma, but it is unlikely to limit more
general (mis)application of the term. Another option would be to encourage the
development of a clearer taxonomy of super-spreading so as to take scientific
ownership of the term and discourage inappropriate lay adoption, potentially
through a classification of behavioural, environmental and biological super-
spreading.
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